ReviewTherapeutic advances in musculoskeletal disease2021

The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritis.

Ali Berkant Avci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.